Esperion Therapeutics, Inc. (ESPR)
2.63
+0.08
(+3.14%)
USD |
NASDAQ |
Mar 23, 16:00
2.63
0.00 (0.00%)
After-Hours: 16:42
Esperion Therapeutics Accounts Payable (Quarterly) : 65.07M for Dec. 31, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Nektar Therapeutics | 10.77M |
| Harrow, Inc. | 35.36M |
| Catalyst Pharmaceuticals, Inc. | 11.20M |
| Rigel Pharmaceuticals, Inc. | 7.191M |
| CytomX Therapeutics, Inc. | 1.301M |